Goodwill (Details) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
|
Sep. 30, 2022
USD ($)
|
Jun. 30, 2022
USD ($)
|
Mar. 31, 2022
USD ($)
|
Sep. 30, 2022
USD ($)
item
|
|
| Goodwill | ||||
| Balance at the end | $ 463,496,191 | $ 463,496,191 | ||
| Acquisitions | 5,201,729 | |||
| Impairment charges | $ 0 | $ 851,500,000 | $ 0 | 851,455,754 |
| Balance at the beginning | $ 1,309,750,216 | $ 1,309,750,216 | ||
| Number of medical practice acquired | item | 2 | |||
| Term of steady decline in share price | 3 months | |||
| Percentage of stock lower than opening price | 63.00% | |||
| X | ||||||||||
- Definition Number of business acquired under business combination. No definition available.
|
| X | ||||||||||
- Definition Percentage of stock lower than opening price. No definition available.
|
| X | ||||||||||
- Definition Term of steady decline in share price. No definition available.
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|